Stocks
Santen Pharmaceutical Co., Ltd.SNPHY
OTCHealthcareBiotechnology$10.14-0.88%
Specializing in ophthalmic pharmaceuticals and medical devices, this company is a key player in treatments for glaucoma, dry eye, and retinal diseases. Investors monitor its pipeline of innovative eye care solutions and global market expansion in Asia and Europe.
Market Cap: $3.3B52W Range: $8.89 – $12.04
Congressional Interest in Santen Pharmaceutical Co., Ltd. (SNPHY)
1 member of Congress has disclosed 1 trade in Santen Pharmaceutical Co., Ltd. (SNPHY), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading SNPHY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-01-27 | Thomas MacArthur | sell | $1K – $15K |